SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,515.43 362.57
( 0.48%)

Global Indices

Nasdaq

53,423.66 -283.45
(-0.53%)

Dow Jones

7,737.34 -31.37
(-0.40%)

Hang Seng

65,002.68 788.20
(1.23%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.48 -0.24
(-0.26%)

EUR-INR

109.71 0.00
(0.00%)

GBP-INR

127.63 -0.19
(-0.15%)

JPY-INR

0.60 0.01
(1.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Asston Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

544445

INE0SJX01015

45.6540372

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

24.22

93.59

EPS(TTM)

Face Value()

Div & Yield %

4.54

Back

Croissance reports consolidated nil net profit/loss in the June 2026 quarter

Aug 05,2026

Croissance reported no net profit/loss in the quarter ended June 2026 as against net profit of Rs 0.01 crore during the previous quarter ended June 2025. Sales reported to Rs 0.03 crore in the quarter ended June 2026. There were no Sales reported during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	0.03	0	0
OPM %	-266.67	0	-
PBDT	0.01	0.01	0
PBT	0.01	0.01	0
NP	0	0.01	-100

76,515.43 362.57 ( 0.48%)

53,423.66 -283.45 (-0.53%)

7,737.34 -31.37 (-0.40%)

65,002.68 788.20 (1.23%)

10,828.70 -2.82 (-0.03%)

94.48 -0.24 (-0.26%)

109.71 0.00 (0.00%)

127.63 -0.19 (-0.15%)

0.60 0.01 (1.60%)